Here are some Tuesday reads to get your day going:
- The analysts at Leerink have been crunching the numbers on what the first hemophilia gene therapies could fetch and it is an estimated $1.5 million.
- The Amish pool resources for their medical care. A budget-busting gene therapy puts them in a bind
- The Unforgiving Math That Stops Epidemics
- Takeda CEO Christophe Weber finally closes on his $62B deal to buy Shire — now he has to convince shareholders and slash jobs
- Ali Rahimi, a researcher in artificial intelligence (AI) at Google in San Francisco, California, took a swipe at his field last December—and received a 40-second ovation for it. Rahimi charged that machine learning algorithms, in which computers learn through trial and error, have become a form of “alchemy.”
Have a great day!